Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14.
about
miR-155 as a Biomarker in B-Cell MalignanciesThe Emerging Role of miR-223 in Platelet Reactivity: Implications in Antiplatelet TherapyGenetic abnormalities in chronic lymphocytic leukemia: where we are and where we goIL-4 Up-Regulates MiR-21 and the MiRNAs Hosted in the CLCN5 Gene in Chronic Lymphocytic Leukemia.Single and Compound Knock-outs of MicroRNA (miRNA)-155 and Its Angiogenic Gene Target CCN1 in Mice Alter Vascular and Neovascular Growth in the Retina via Resident MicrogliaDeregulated Levels of the NF-κB1, NF-κB2, and Rel Genes in Ukrainian Patients with Leukemia and Lymphoma in the Post-Chernobyl Period.State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia.Cytogenetic Abnormalities with Interphase FISH Method and Clinical Manifestation in Chronic Lymphocytic Leukemia Patients in North-East of Iran.Role of miR-15a/miR-16-1 and the TP53 axis in regulating telomerase expression in chronic lymphocytic leukemiaCombining cytogenetic and epigenetic approaches in chronic lymphocytic leukemia improves prognosis prediction for patients with isolated 13q deletion.Influence of clone and deletion size on outcome in chronic lymphocytic leukemia patients with an isolated deletion 13q in a population-based analysis in British Columbia, Canada.Assessment of micro RNAs expression in leukemic cells as prognostic markers in chronic lymphocytic leukemia: micro RNAs can predict survival in a course of the disease.Biallelic losses of 13q do not confer a poorer outcome in chronic lymphocytic leukaemia: analysis of 627 patients with isolated 13q deletionRole of miR-223 in the pathophysiology of liver diseases
P2860
Q26746573-AF81A9FA-D335-4BBD-84D5-4B03BB750C2FQ26801874-E96B2F26-7BFB-49FC-8560-AB0B1B86C1D8Q33744997-3D2D99EE-D80F-43A3-ADBF-BAE3036C3B1DQ35613623-090D201C-4841-4103-A2FA-2485C2B3389EQ36281635-8EA0F3DE-0CC2-4138-8CBD-D1999FD87EF3Q36722779-C5EC5CF3-B647-40A3-84D6-3950A34CDBA9Q39085428-B9322B42-F56B-404E-B3CE-AEB2EAE34419Q42228343-A4CB711C-CB3E-4101-A47F-0171CC0EF8D1Q42348459-3AE49ED2-1546-4BFA-8D32-57EE5DBFE4EBQ47133291-D15FB24D-5BD1-43FA-945C-8B227E9ABA3AQ47360579-B8503345-3E56-4927-B8CD-6F86E59E8291Q55182677-B140C84C-377E-4461-A59F-57E4009D44D6Q58041435-AB2E2293-97ED-423E-BC87-7351F7D1A4B7Q58695698-92867711-9576-4563-9446-7D755707DC95
P2860
Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Molecular characterization of ...... igh number of losses in 13q14.
@ast
Molecular characterization of ...... igh number of losses in 13q14.
@en
Molecular characterization of ...... igh number of losses in 13q14.
@nl
type
label
Molecular characterization of ...... igh number of losses in 13q14.
@ast
Molecular characterization of ...... igh number of losses in 13q14.
@en
Molecular characterization of ...... igh number of losses in 13q14.
@nl
prefLabel
Molecular characterization of ...... igh number of losses in 13q14.
@ast
Molecular characterization of ...... igh number of losses in 13q14.
@en
Molecular characterization of ...... igh number of losses in 13q14.
@nl
P2093
P2860
P50
P1433
P1476
Molecular characterization of ...... high number of losses in 13q14
@en
P2093
Alberto Risueño
Alfonso García de Coca
Encarna Fermiñán
Guillermo Martín-Núñez
Isabel Recio
Jose Ángel Hernández
Marcos González
María Hernández-Sánchez
Norma C Gutiérrez
Oliver Gutiérrez
P2860
P304
P356
10.1371/JOURNAL.PONE.0048485
P407
P50
P577
2012-11-13T00:00:00Z